{
  "id": 11230700,
  "title": "Novel treatment combination improves progression-free survival in most common form of metastatic breast cancer",
  "url": "https://urgent.news/2026/10/01/novel-treatment-combination-improves-progression-free-survival-in",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-01T16:00:05.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-10-treatment-combination-free-survival-common.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "Patients with estrogen receptor-positive (ER+), HER-2-negative advanced breast cancer experienced significantly improved progression-free survival (PFS) when treated with an oral combination regimen that included giredestrant, a novel, next-generation selective ER degrader and full antagonist (SERD), compared with a standard combination approach. These findings, from the phase 3 evERA Breast…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}